Global Continuous Subcutaneous Insulin Therapy Devices (CSITD) Market 2019-2023

The continuous subcutaneous insulin therapy devices (CSITD) market size will grow by over USD 1,812 million during 2019-2023. This report offers an analysis of the market based on product segmentation (tethered and patch). The continuous subcutaneous insulin therapy devices market research report further presents in-depth insights on the growth prospects of the market across geographic regions- the Americas, APAC, and EMEA. The report also provides an analysis of the market’s competitive landscape and offers information on several companies including Cellnovo, F. Hoffmann-La Roche, Insulet, Medtronic, and Tandem Diabetes Care.

Below are some of the key findings from the continuous subcutaneous insulin therapy devices market analysis report

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.

Get a FREE sample now!  

Global Continuous Subcutaneous Insulin Therapy Devices Industry Overview

Technological advances will trigger the growth of global continuous subcutaneous insulin therapy devices market during the forecast period. The high incidence of diabetes has increased the demand for diabetes management products such as CSITD in the market. So, the vendors of this market focus on developing innovative & better technologies. For instance, Medtronic utilizes advanced technologies like SmartGuard and Guardian Sensor 3 for developing their product. Guardian Sensor 3 technology is one of the most accurate technologies available for continuous glucose monitoring, whereas SmartGuard technology is the only available smart algorithm, which can adapt to fluctuating glucose levels and self-adjust insulin delivery. Thus, the growing demand of such technological advances will drive the growth of the global continuous subcutaneous insulin therapy devices market at a CAGR of over 9% during the forecast years.

Top continuous subcutaneous insulin therapy devices companies covered in this market research report

The continuous subcutaneous insulin therapy devices market is moderately concentrated owing to the presence of several market players. These players are leveraging advanced technologies to offer high-quality products to meet the evolving needs of the end-user industries. By offering a complete analysis of the market’s competitive landscape and with information on the applications offered by the companies, this continuous subcutaneous insulin therapy devices industry analysis report will allow the clients to identify new growth opportunities and design innovative strategies for improving their share in the market.

The report offers a complete analysis of various companies including:

• Cellnovo
• F. Hoffmann-La Roche
• Insulet
• Medtronic
• Tandem Diabetes Care

Continuous subcutaneous insulin therapy devices market segmentation based on geographic regions

• Americas
• APAC
• EMEA

With a complete study of the growth opportunities for the companies across regions such as the Americas, APAC, and EMEA, our industry research analysts have estimated that countries in the Americas region will contribute to the highest growth of this market throughout the forecast period. The increasing incidence of diabetes has increased the demand of the continuous subcutaneous insulin therapy devices market in this region.

Continuous subcutaneous insulin therapy devices market segmentation based on products

• Tethered
• Patch

According to our market research experts, the tethered segment will account for the highest growth in the continuous subcutaneous insulin therapy devices market. Additionally, the report also provides an accurate prediction of the contribution of the various application segments to the growth of the continuous subcutaneous insulin therapy devices market size.

Key highlights of the global continuous subcutaneous insulin therapy devices market for the forecast years 2019-2023:

• CAGR of the market during the forecast period 2019-2023
• Detailed information on factors that will accelerate the growth of the continuous subcutaneous insulin therapy devices market during the next five years
• Precise estimation of the global continuous subcutaneous insulin therapy devices market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the continuous subcutaneous insulin therapy devices industry across various geographies such as the Americas, APAC, and EMEA
• A thorough analysis of the market’s competitive landscape and detailed information on several vendors
• Comprehensive information about factors that will challenge the growth of continuous subcutaneous insulin therapy devices companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch